| HAA | hearing aid amplifier; hemolytic anemia antigen; hepatitis-associated antigen; hospital activity ana... |
|---|---|
| MAA | macroaggregated albumin; Medical Assistance for the Aged; melanoma-associated antigen; moderate apla... |
| MAP | malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ... |
| AAN | AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o... |
| DAA | decompensated autonomous adenoma; dementia associated with alcoholism; dialysis-associated amyloidos... |
| hepatitis-associated antigen | A term used for the surface antigen of hepatitis B virus before its nature was established. See: hepatitis B surface antigen. (05 Mar 2000) |
|---|---|
| scaffold-associated regions | Sites in DNA that bind topoisomerase II and other scaffold proteins; found in introns. (05 Mar 2000) |
| herpes virus, kaposi sarcoma-associated | Species of an unnamed genus, subfamily gammaherpesvirinae, isolated from patients with aids-related and "classical" kaposi sarcoma. The sequences suggest this is a new human herpes virus, unofficially identified as human herpes virus-8 (hhv-8). (12 Dec 1998) |
| human leukaemia-associated antigens | Antigen's on the surface of leukaemic cells which seem not to be present on the surfaces of the same type of normal cells; the myeloblast antigen of acute myelogenous leukaemia found in chronic myelogenous leukaemia is thought to be associated with a "blastic" transformation. (05 Mar 2000) |
| human leukocyte-associated antigens | Proteins on the outer part of body cells that help fight illness. These proteins vary from person to person. Scientists think that people with certain types of HLA antigens are more likely to develop insulin-dependent diabetes.The HLA antigens are also responsible for histocompatibility reactions. (09 Oct 1997) |
| stomach cancer-associated protein-tyrosine phosphatase | <enzyme> Human transmembrane-type ptpase expressed in gastric, pancreatic and colourectal cancer cells; consists of 1093 amino acid; mw 200 kD; genbank d15049 Registry number: EC 3.1.3.- Synonym: sap 1 phosphatase (26 Jun 1999) |
| neurofilament-associated kinase | <enzyme> Phosphorylates a subset of peptides in vitro which are phosphorylated in vivo in cultured neurons Registry number: EC 2.7.1.- Synonym: naf kinase (26 Jun 1999) |
| NS5A-associated kinase | <enzyme> Involved in the phosphorylation of the hepatitis c virus ns5a nonstructural protein in vitro and in vivo Registry number: EC 2.7.10.- (26 Jun 1999) |
| I kappa B alpha-associated protein kinase | <enzyme> Isolated from human monocytic cell line; phosphorylates ser(293), ser(288), and thr(291) of ikappabalpha Registry number: EC 2.7.10.- Synonym: ikappabalpha-associated protein kinase, ikappab-alpha-associated protein kinase, ikappabalpha kinase (26 Jun 1999) |
| Ir associated antigen | Antigens coded for by IR (immune response) genes or antigens coded for by the genome close to the IR genes. See: Ia antigens. (18 Nov 1997) |
| I region associated antigens | Class II major histocompatibility (MHC) antigens. (18 Nov 1997) |
| islet neogenesis-associated protein | <chemical> Constituent of ilotropin; stimulates proliferation of pancreatic ductal cells in vitro; from hamsters and humans; amino acid sequence given in first source Synonym: ingap protein, ingap gene product (05 Dec 1998) |
| tat-associated kinase | <enzyme> Abbreviated tak; binds to activation domain of tat Registry number: EC 2.7.1.- Synonym: p-tefb, positive transcriptional elongation factor b (26 Jun 1999) |
| encephalomyelitis associated with carcinoma | An encephalomyelopathy as a remote effect of carcinoma, most often oat cell carcinoma of the lung; characterised by extensive nerve cell loss, which may be diffuse, but often predominates in particular portions of the central nervous system, particularly the limbic lobes, medulla, cerebellum, and gray matter of the spinal cord. Synonym: carcinomatous encephalomyelopathy, encephalomyelitis associated with carcinoma, paracarcinomatous encephalomyelopathy. (05 Mar 2000) |
| ergot alkaloid-associated heart disease | Heart disease caused by endomyocardial fibrosis which extends into valve structures, producing stenosis and/or regurgitation, associated with ergot alkaloid use. (05 Mar 2000) |